← Back to Search

blood flow restriction for Anterior Cruciate Ligament Injury

N/A
Waitlist Available
Led By Arny A Ferrando, Ph.D.
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16-weeks post-surgery
Awards & highlights

Study Summary

This trial will test whether adding PBFR to PT can improve outcomes for people who've had ACL surgery.

Eligible Conditions
  • Anterior Cruciate Ligament (ACL) Injury
  • Anterior Cruciate Ligament Injury

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16-weeks post-surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16-weeks post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Maximal Voluntary Contraction

Trial Design

2Treatment groups
Experimental Treatment
Group I: physical therapy without blood flow restrictionExperimental Treatment1 Intervention
Standard of care.
Group II: physical therapy with blood flow restrictionExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,289 Total Patients Enrolled
Arny A Ferrando, Ph.D.Principal InvestigatorUniversity of Arkansas
3 Previous Clinical Trials
48 Total Patients Enrolled
~1 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top